Follow us on Twitter
twitter icon@FreshPatents

Gly patents

Bulk PDF Downloads
      

This page is updated frequently with new Gly-related patent applications.




 Coating composition for transparent electrode passivation layer and transparent electrode having passivation layer patent thumbnailCoating composition for transparent electrode passivation layer and transparent electrode having passivation layer
Provided is a coating composition for a transparent electrode passivation layer, the coating composition including a metal oxide and at least one selected from the group consisting of ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol, and tetraethylene glycol. When a passivation layer formed using the coating composition for a transparent electrode passivation layer according to the present invention is applied to a transparent electrode, the passivation layer is capable of ensuring the heat resistance and durability of the transparent electrode while maintaining the transmittance of the transparent electrode.
Korea Institute Of Machinery And Materials


 Biomarker for rheumatoid arthritis diagnosis or activity evaluation patent thumbnailBiomarker for rheumatoid arthritis diagnosis or activity evaluation
The present invention relates to a composition and kit for rheumatoid arthritis diagnosis or activity evaluation, the composition and kit each including an agent for measuring the concentration of at least one protein selected from a group consisting of soluble cd14 (scd14), a-1-acid glycoprotein 1 (agp1), and a-1-acid glycoprotein 2 (agp2). Further, the present invention relates to a use of the composition for diagnosing rheumatoid arthritis or evaluating activity..
Catholic University Industry-academic Cooperation Foundation


 Methods compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging patent thumbnailMethods compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging
Methods, compositions, systems, devices and kits are provided herein for preparing and using a nanoparticle composition and spatial frequency heterodyne imaging for visualizing cells or tissues. In various embodiments, the nanoparticle composition includes at least one of: a nanoparticle, a polymer layer, and a binding agent, such that the polymer layer coats the nanoparticle and is for example a polyethylene glycol, a polyelectrolyte, an anionic polymer, or a cationic polymer, and such that the binding agent that specifically binds the cells or the tissue.
Rhode Island Hospital


 Melt compounding and fractionation of lignocellulosic biomass and products produced therefrom patent thumbnailMelt compounding and fractionation of lignocellulosic biomass and products produced therefrom
Methods and processes to fractionate and/or convert cellulosic material into accessible sugar and chemical intermediates is provided. A method of embodiments of the invention includes processing lignocellulosic biomass by mixing lignocellulosic biomass and glycerol to form a biomass slurry, and heating and shearing the biomass slurry at a temperature ranging from 100° c.
Virginia Tech Intellectual Properties, Inc.


 An electron consuming ethanol production pathway to displace glycerol formation in s. cerevisiae patent thumbnailAn electron consuming ethanol production pathway to displace glycerol formation in s. cerevisiae
The present invention provides for a mechanism to completely replace the electron accepting function of glycerol formation with an alternative pathway to ethanol formation, thereby reducing glycerol production and increasing ethanol production. In some embodiments, the invention provides for a recombinant microorganism comprising a down-regulation in one or more native enzymes in the glycerol-production pathway.
Lallemand Hungary Liquid Management Llc


 Compositions and methods for differential regulation of fatty acid unsaturation in membrane lipids and seed oil patent thumbnailCompositions and methods for differential regulation of fatty acid unsaturation in membrane lipids and seed oil
Aspects of the invention provide methods for differential regulation of fatty acid unsaturation in seed oil and membrane lipids of plants based on modulation of a previously unknown biosynthetic pathway involving a novel phosphatidylcholine:diacylglycerol cholinephosphotransferase (pdct) that regulates phosphatidylcholine biosynthesis in developing oil seed plants. Specific aspects relate to inventive pdct polypeptides including, for example, variants, deletions, muteins, fusion proteins, and orthologs thereof (collectively pdct proteins), to nucleic acids encoding same, to plants comprising such pdct sequences or proteins or devoid or depleted of such pdct proteins or sequences, and to methods for generating plants having altered or no pdct expression and/or activity, including but not limited to methods comprising mutagenesis, recombinant dna, transgenics, etc..
Washington State University


 Activated sugars patent thumbnailActivated sugars
Kinase and nucleotidyltransferase enzymes for the production of activated sugars have been developed. These enzymes have improved stability for industrial application and relaxed specificity towards a variety of sugars.
Zuchem, Inc.


 Soluble hiv-1 envelope glycoprotein trimers patent thumbnailSoluble hiv-1 envelope glycoprotein trimers
The present application relates to novel hiv-1 envelope glycoproteins which may be utilized as an hiv-1 vaccine immunogens, antigens for crystallization and for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention..
The Scripps Research Institute


 The use of polyalkylene glycol esters in lubricating oil compositions patent thumbnailThe use of polyalkylene glycol esters in lubricating oil compositions
The presently claimed invention is directed to the use of polyalkylene glycol ester that are prepared by reacting polytetrahydrofuran with at least one c9-c27 acid in lubricating oil compositions.. .
Basf Se


 Use of a polyalkylene glycol to reduce fuel consumption patent thumbnailUse of a polyalkylene glycol to reduce fuel consumption
The use of a polyalkylene glycol of formula ho-(a-o)p—(ch2ch2—o)m-(a-o)q—h wherein a is a c3- to c20-alkylene group or a mixture of such alkylene groups, m is a number of from 2 to 100 and p and q are each numbers of from 1 to 100, as an additive in a fuel.. .
Basf Se


Antifreeze solution, depletion prevention agent for a plant and heating medium solution


An antifreeze solution includes a urea, a surfactant, a purified glycerol, and one of water and alkaline reducing water. The combination of the urea, the surfactant, the purified glycerol, and the water or the alkaline reducing water can be used for a depletion prevention agent for a plant, and can be used for a heating medium solution..

Azlactone based thermally crosslinkable polymer coating for controlling cell behavior


Random copolymers, crosslinked thin films of the random copolymers and cell culture substrates comprising the crosslinked thin films are provided. Also provided are methods of making and using the copolymers, thin films and substrates.
Wisconsin Alumni Research Foundation


Slip preventing agent for socks


A slip preventing agent for socks of the present invention contains an acrylic acid based polymer, glycerin, and a fatty acid dextrin. It is preferred that an amount of the fatty acid dextrin in the slip preventing agent for socks is in the range of 0.05 to 1 mass %.
Nippon Zettoc Co., Ltd.


Ink formulations for improving printhead lifetime


(ii) a glycol compound selected from the group consisting of: triethylene glycol, tetraethylene glycol and pentaethylene glycol; and (iv) water.. .

Polyoxymethylene nanoparticles


The synthesis of nanoparticles based on hyperbranched-linear-hyperbranched aba triblock copolymers with hyperbranched polyglycerol (hbpg) as a-block and linear poly(oxymethylene) as b-block is described. The acid-degradable nanoparticles were formed in a facile process, combining a solvent evaporation process with the miniemulsion technique resulting in particles with a diameter in the range of 190 to 250 nm and a standard deviation of ˜30% determined with dls and sem.
Ticona Gmbh


Stable polyethylene glycol particle dispersions and methods for forming the stable dispersions


Stable dispersions of solid polyethylene glycol particles are described in polyalkylene glycol liquids. The stable dispersions have an increased viscosity relative to the liquids without the suspended particles.
Psmg, Llc


Stearic acid derivatives and oleic acid derivatives of multi-arm polyethylene glycol


Disclosed are multi-arm polyethylene glycol derivatives having structure of formula i or formula vi. Compared with straight chain polyethylene glycol, multi-arm polyethylene glycol has a plurality of terminal groups, thus has a plurality of introducing points of functional groups and can support a plurality of reactive terminal groups, thereby enabling multi-arm polyethylene glycol to have more flexibility and wider range of application..
Jenkem Technology Co., Ltd. (tianjin)


Anti-garp protein and uses thereof


The present invention relates to an antibody binding to the transmembrane protein ‘glycoprotein a repetitions predominant’ (garp) in the presence of tgf-β and uses thereof.. .
Argen-x N.v.


Production of recombinant proteins with simple glycoforms


The present invention provides cell lines deficient in mannosyl (alpha-1,3-)-glycoprotein beta-1,2-n-acetylglucosaminyltransferase i (mgat1). Also provided are methods for producing the mga1 deficient cell lines and methods for using the mgat1 deficient cell lines for the production of recombinant proteins having simple glycoforms..
Sigma-aldrich Co. Llc


Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Protamine in treatment of neuronal injuries


The present invention relates to treatment of neuronal injury. The present invention discloses a novel use of an agent and a novel method for promoting neurite out growth and/or neural regeneration in cns injuries.
University Of Helsinki


Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains


The invention is directed to glycopeptide antibiotics and their aglycones that are engineered to overcome bacterial resistance by replacement of a single, specific peptide carboxamide group in the core peptide of the glycopeptide antibiotic with an amidine group. The amidine pseudopeptide analog of the glycopeptide is effective in killing vancomycin-resistant bacteria at therapeutically achievable concentrations in a patient.
The Scripps Research Institute


Dgat1 inhibitor and preparation method and use thereof


The present invention discloses a novel dgat1 inhibitor, especially the compound of formula (i) or a pharmaceutically acceptable salt thereof, preparation and pharmaceutical composition thereof, as well as their uses in the preparation of a medicament for the prevention and treatment of familial hyperchylomicronemia (fcs), obesity, hyperlipoproteinemia or hypertriglyceridemia.. .
Medshine Discovery Inc.


Continuous arycyclic compound


This is to provide a continuous arycyclic compound having a dgat1 inhibitory activity, and useful for prophylaxis and/or treatment of obesity or hyperlipidemia caused by obesity, hypertriglyceridemia, lipid metabolism disorder, fatty liver, hypertension, arteriosclerosis, diabetes, etc., as well as to provide a dgat1 inhibitor comprising the continuous arycyclic compound or a pharmaceutically acceptable salt thereof as an effective ingredient. Disclosed is the continuous arycyclic compound is represented by the formula: wherein the substituents in the formula are the same as defined in the specification, or a pharmaceutically acceptable salt thereof..
Mitsubishi Tanabe Pharma Corporation


Compositions and methods for the treatment of hyperglycemia and metabolic syndrome


The invention relates to the compounds and compositions of formula i, formula ii, formula iii, formula iv, formula v, formula vi or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprises a salt of metformin and the methods for treating or preventing metabolic syndrome, prediabetes and diabetes may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection.

Supported metal catalyst and use thereof for selective oxidation of glycerol


A method for oxidation of glycerol into glyceric acid is described, which includes a step of treating glycerol with a supported metal catalyst in the presence of oxygen, said catalyst including platinum and a metal element selected from the group comprising tin, molybdenum, bismuth and a mixture thereof.. .
Franck Dumeignil


Alkynyl multi-arm polyethylene glycol derivative


The present invention provides an alkynyl multi-arm polyethylene glycol derivative having a structure of a general formula i or general formula x viii. In the derivative, x1, x2, x3 and x4 are linking groups, f1, f2, f3 and f4 are end groups, the end groups may be the same or may also be different, and are selected from: hydroxy, carboxyl, ester group, amino, alkynyl or the like, at least one of the end groups is alkynyl, and peg is the same or different —(ch2ch2o)m—, wherein m is an integer ranging from 3 to 250, and 1 is an integer greater than or equal to 1.
Jenkem Technology Co., Ltd. (beijing)


Multi-arm polyethylene glycol-azido derivative


Provided is a multi-arm polyethylene glycol-azido derivative of general formula i , wherein r is a central molecule,which is selected from a polyhydroxy structure, a polyamino structure or a polycarboxyl structure; n is the number of branches or arms, n 3; peg is the same or different —(ch2ch2o)m—, the average value of m being an integer from 3 to 250; x is a linking group of a azido end group; k is the number of the branches having the azido end group; f is selected from the group consisting of amino, carboxyl, sulfhydryl, ester group, maleic imide group and acrylic group; and y is a linking group of an end group f.. .
Jenkem Technology Co., Ltd.


Acylated glucagon analogues


The present invention relates to novel peptide compounds which have an improved physical stability in solution and improved solubility at neutral ph, to the use of the compounds in therapy, to methods of treatment comprising administration of the compounds to patients in need thereof, and to the use of the compounds in the manufacture of medicaments. The compounds of the invention are of particular interest in relation to the treatment of hyperglycemia, diabetes and obesity, as well as a variety of diseases or conditions associated with hyperglycemia, diabetes and obesity..
Novo Nordisk A/s


Bunyaviruses with segmented glycoprotein precursor genes and methods for generating these viruses


The invention relates to a bunyavirus, in which separated (nsm)gn and gc coding regions are functionally present on two different genome segments, preferably a bunyavirus that comprises a total of at least 4 genome segments. The invention further relates to methods for producing said bunyavirus, and to a composition comprising said bunyavirus and a suitable excipient..
Stichting Dienst Landbouwkundig Onderzoek


Vitamin formulations


The present invention provides formulations for enhancing bioavailability of watersoluble compounds including water-soluble vitamins. The formulations include a watersoluble vitamin and a glycoside selected from a diterpene glycoside and a triterpene glycoside.
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College


Pharmaceutical composition for cleansing of the gastrointestinal tract


A pharmaceutical composition for cleansing the gastrointestinal tract prior to a colonoscopy or other gastrointestinal procedure is provided. The composition comprises polyethylene glycol and sodium picosulfate and is suitable to make up to 1.5 liters of aqueous solution for oral administration..
Oakdene Holdings Llc


Polyethylene glycol-cactus oligopeptide bonding rapamycin derivatives


The present invention provides compounds represented by formula (i) and pharmaceutical acceptable salts thereof, preparation method therefor and pharmaceutical composition containing the compounds represented by formula (i) and pharmaceutical acceptable salts thereof. In the compounds of the present invention, each terminal group of polyethylene glycol molecule can bond with a plurality of rapamycin molecules by cactus oligopeptide, with the loading rate of the pharmaceutical being increased.
Jenkem Technology Co., Ltd.


Methods and compositions for improving cognitive function


The invention relates to compositions comprising a synaptic vesicle glycoprotein 2a (sv2a) inhibitor in an extended release and an acetylcholinesterase inhibitor (acheis). The invention also relates to using such compositions in treating cognitive impairment associated with central nervous system disorders in a subject in need or at risk thereof, including, without limitation, subjects having or at risk for age-related cognitive impairment, mild cognitive impairment (mci), dementia, alzheimer's disease (ad), prodromal ad, post traumatic stress disorder (ptsd), schizophrenia, bipolar disorder, amyotrophic lateral sclerosis (als), cancer-therapy-related cognitive impairment, mental retardation, parkinson's disease (pd), autism, compulsive behavior, and substance addiction..
Agenebio Inc.


Agent in suppository form for the treatment of haemorrhoids, proctitis and other inflammatory proctological disorders


The invention relates to a medicinal agent to treat hemorrhoid, proctitis and other inflammatory proctology diseases. Said medicinal agent represents a suppository with a mass of 1.35 to 3.65 g and comprises, as active ingredients, 0.3 to 0.65 g of diosmin, 0.05 to 0.2 g of dexpanthenol, 0.05 to 0.2 g of green tea extract, and, as auxiliary substances, 0.0135 to 0.1825 g of emulsifier and fatty acid glycerides.
Obschestvo S Ogranichennoi Otvetstvennostyu "gemodan"


Shell-forming compositions for soft capsules and soft capsules


A shell-forming composition for a soft capsule comprising a non-gelatin component as the chief component, wherein the shell-forming composition is able to inhibit a decrease in physical strength (breaking strength) of the capsule when a phospholipid-containing oil with a phospholipid concentration of 20% or more by mass is used as the core of the capsule. The shell-forming composition for the soft capsule comprises (a) starch and/or dextrin, (b) a gelatinizer, (c) glycerin and (d) sorbitol, and the mass ratio of (c) glycerin:(d) sorbitol ranges from 100:30 to 100:120..
R.p. Scherer Technologies, Llc


Use of stabilized granules containing glyceryl trinitrate for arteriogenesis


The present invention inter alia relates to a method of treating or preventing an arterial insufficiency, where an no donor is administered in an intermitting manner to a subject in an amount of effective for the induction of arteriogenesis, and wherein the no donor is a solid pharmaceutical preparation with the active substance glyceryl trinitrate for oromucosal or oral administration characterized in that it contains between 0.05 and 2 weight % glyceryl trinitrate (gtn), at least one diluent, one carrier material, and at least one substance that reduces the volatility of gtn, whereby this substance is a non-volatile ester stabilizer whose melting point is not higher than 60° c.. .
G. Pohl-boskamp Gmbh & Co. Kg


Styling spray having a volume effect


The invention relates to an aerosol composition, comprising a) a cosmetic styling product, including a1) at least one polyalcohol selected from the group comprising glycerol, propylene glycol, and panthenol, in particular glycerol, a2) polymer including carboxylic acid groups, wherein at least 50 wt % of the polymer including carboxylic acid groups is a copolymer formed by the monomers, a2i) n-tert.-octylacrylamide, a2ii) acrylic acid, a2iii) tert.-butylaminoethylmethacrylic acid and optionally further monomers, characterised in that the ratio of the parts by weight of component a1) and component a2) in the product is greater than 1, b) a propellant or mixture of propellants, when used for temporary deformation of keratin fibres are distinguished by improved sheen, good volume, and improved feel of the hair.. .
Henkel Ag & Co. Kgaa


Odor-reduced agent for smoothing or permanently shaping hair or for depilation


An agent for straightening, permanently shaping, or depilation of keratinous fibers comprising, (a) at least one linear alkan-1-ol or alken-1-ol in each case having 20-22 carbon atoms, wherein the at least one alken-1-ol has one to four olefinic double bonds, in a total quantity of 1.8 to 10.0% by weight, and (b) at least one glyceryl fatty acid ester of general formula (i), wherein r1, r2, and r3 independently stand for a hydrogen atom or a group of formula (ii), r4 stands for an unbranched or branched, saturated or unsaturated cu11-c27 alkyl group, with the condition that at least one and at most two of the moieties selected from r1, r2, and r3 is a group of formula (ii), (c) water, and (d) at least one keratin-reducing compound selected from thioglycolic acid or salts thereof, thiolactic acids or salts thereof, cysteine, acetylcysteine, cysteamine, or salts thereof, and mixtures thereof.. .
Henkel Ag & Co. Kgaa


Skin renewal enhancer


A system for enhancing skin renewal is provided, including a first phase having an anhydrous solvent, a hydroxy acid, and urea, and a second phase having a neutralizing agent and optional abrasive. A composition is provided, wherein the first phase includes glycerin, lactic acid, and urea, and wherein the second phase includes a neutralizing agent and optional abrasive.

Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Method, system, and monitoring and treating hypoglycemia


A system and method for monitoring a patient's blood glucose levels and communicating such levels to a patient care network is provided. More particularly, a monitor for measuring blood glucose levels may be adapted to alert the patient and preselected members of the patient care network in the event that the patient's blood glucose levels fall below a threshold amount.

System and non-reductive beta-elimination isolation and analysis


A laboratory method and system used to isolate and analyze o-linked oligosaccharides from glycoproteins that uses non-reductive β-elimination (nbre). The method including the step of providing a predetermined amount of solution and then passing it through an ion exchange resin.

Compositions and methods for diagnosing and/or treating influenza infections


The present invention provides ha polypeptides (e.g., h1 ha polypeptides) that bind to umbrella-topology glycans, and reagents and methods relating thereto. The present invention provides binding agents that bind to ha polypeptides (e.g., h1 ha polypeptides), and reagents and methods relating thereto.
Massachusetts Institute Of Technology


Antifoaming agents for the paper industry, based on oil in water emulsions


The present invention which provides antifoaming agents for the paper industry, based on oil-in-water emulsions, in which the oil phase accounts for from 5 to 50% by weight of the emulsion if the oil phase of the emulsions contains (a) an alcohol of not less than 12 carbon atoms, fatty esters of alcohols of not less than 22 carbon atoms and c1-c36-carboxylic acids, distillation residues which are obtainable in the preparation of alcohols having a relatively large number of carbon atoms by the oxo synthesis or by the ziegler method and which may furthermore be alkoxylated, a mixture of the stated compounds and (b) optionally a fatty ester of a c12-c22-carboxylic acid with a monohydric to trihydric c1-c18-alcohol and, (c) optionally a hydrocarbon having a boiling point above 200° c. Or a fatty acid of 12 to 22 carbon atoms, in combination with from 1 to 80% by weight of component (d) comprising (d1) polyglyceryl esters which are obtainable by not less than 20% esterification of a polyglycerol mixture of from 0 to 10% by weight of monoglycerol, from 15 to 40% by weight of diglycerol, from 30 to 55% by weight of triglycerol, from 10 to 25% by weight of tetraglycerol, from 0 to 15% by weight of pentaglycerol, from 0 to 10% by weight of hexaglycerol and from 0 to 5% by weight of polyglycerols having higher degrees of condensation with one or more fatty acids of 12 to 36 carbon atoms; and (d2) c18-c30 alkyl behenate.
Basf Se


Bacteria and synthesizing fatty acids


There is provided a recombinant bacterium comprising at least one overexpressed acyl-acp thioesterase gene, and wherein at least one gene from the tricarboxylic acid cycle or glycolysis or both is inactivated. There is also provided a method for producing fatty acids, said method comprising culturing bacteria comprising at least one overexpressed acyl-acp thioesterase gene in a growth medium in a container having walls; allowing said bacteria to secrete fatty acids; and collecting said fatty acids.
William Marsh Rice University


Recombinant glycoproteins and uses thereof


Provided herein are recombinant glycoproteins (e.g., recombinant human α-galactosidase-a proteins) with an altered (e.g., improved) glycosylation profile, and pharmaceutical compositions and kits including one or more of these proteins. Also provided are methods of generating a mammalian cell useful for recombinant expression of a glycoprotein (e.g., recombinant human α-galactosidase-a), methods of producing recombinant glycoproteins, and methods of treatment that include administering to a subject at least one of the recombinant glycoproteins (e.g., recombinant human α-galactosidase-a protein)..
Genzyme Corporation


Lubricant composition based on polyglycerol ether


A lubricant composition includes at least one branched polyglycerol ether, and more particularly at least one branched polyglycerol ether and at least one dispersant. A method for reducing fuel consumption of a vehicle utilizing a lubricant composition is also provided.
Total Marketing Services


Method for producing high quality biodiesel fuel


The purpose of the present invention is to provide a method for producing a high quality biodiesel fuel having excellent oxidation stability and few low-temperature deposits. This purpose can be achieved by the following: hydrogenating a biodiesel fuel so as to selectively convert unsaturated fatty acid monoglycerides and then removing fatty acid monoglycerides through precipitation; or using an adsorbent to further remove fatty acid monoglycerides to a high degree from the biodiesel fuel produced using the method mentioned above..
National Institute Of Advanced Industrial Science And Technology


Method of producing kneading-type antistatic agent


The present invention is to provide a kneading-type antistatic agent which can be obtained through polymerization simply and conveniently by irradiating active energy rays, and a kneading-type antistatic agent which can be kneaded into a thermoplastic resin, thereby imparting excellent permanent antistatic properties to a molded article without affecting the appearance of the molded article. Therefore, the antistatic agent is a kneading-type antistatic agent which is a thermoplastic polymer obtained by irradiating active energy rays toward a solution which contains a ingredient: a polymerizable monomer containing in one molecule one polyalkylene glycol and one polymerizable functional group selected from an acryloyl group and a methacryloyl group, b ingredient: perchlorate and c ingredient: photo polymerization initiator..
Riken Vitamin Co., Ltd.


Modeling material for forming photofabrication model in ink-jet three dimensional printing, supporting material for supporting the shape of photofabrication model on photofabrication and production photofabrication model


The present invention aims to provide a supporting material for supporting the shape of a photofabrication model on photofabrication in ink-jet three dimensional printing method in which the photocured product is excellent in solubility in water and is easy to remove after photofabrication, and the like. A modeling material for forming a photofabrication model in ink-jet three dimensional printing method containing a curable resin component with a weighted average of sp value of 9.0 to 10.3; and a supporting material for supporting the shape of a photofabrication model on photofabrication in ink-jet three dimensional printing method containing a water-soluble monofunctional ethylenically unsaturated monomer (f), polyoxypropylene glycol with a number average molecular weight of 100 to 5,000 and/or water (g), and a photopolymerization initiator (d)..
Keyence Corporation


Glycan-interacting compounds and methods of use


The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives and fragments thereof as well as compositions and kits comprising them..
Siamab Therapeutics, Inc.


Glycans as functional cancer targets and antibodies thereto


A glycan having the structure galβ1-3glcnacβ1-3galβ1-4(fucα1-3)glcnac (leclex) which is attached to a lipid or protein backbone, and isolated binding members capable of binding thereto.. .
The University Of Nottingham


Antibody having broad neutralization activity against group 1 influenza a viruses


From pbmcs of patients infected with h1n1pdm, three human monoclonal antibodies have been obtained which are capable of binding to an epitope present at residues 40 to 58 in an ha2 region of a hemagglutinin protein derived from h1n1pdm. Further, these antibodies have been found to also have a neutralization activity against subtype h1 and subtype h5 of group 1 influenza a viruses.
Department Of Medical Sciences


Human monoclonal antibodies against the middle east respiratory syndrome coronavirus (mers-cov) and engineered bispecific fusions with inhibitory peptides


The invention provides polypeptides (e.g., antibodies) and fusion proteins that target a epitope in the receptor binding domain (rbd) of the spike (s) glycoprotein of the middle east respiratory syndrome coronavirus (mers-cov). The polypeptides and fusion proteins can be used to treat and prevent mers-cov infection in mammals..
The University Of Hong Kong


Glycoprotein hormone long-acting superagonists


This invention provides long-acting, superactive analogs of glycoprotein hormones demonstrating enhanced bioactivity both in vitro and in vivo as compared to wild type counterparts. The analogs are particularly useful for treating subjects showing low receptor expression or poor receptor responsiveness, and for the treatment of any condition associated with glycoprotein hormone activity..
Trophogen Inc.


Cyclic peptide binder against oncogenic k-ras


Selectively bind the oncoprotein k-ras g12d in vitro and in cellulo, where z1 and z2 are each l-propargylglycine (pra), azidoornithine (ornn3), or l-azidolysine (az4), and v1-v2-v3-v4-v5 is an amino acid variable region having a sequence selected from the group consisting of seq id nos: 1-20.. .

Nuclear sulfated oxysterol, potent regulator of lipid homeostasis, for therapy of hypercholesterolemia, hypertriglycerides, fatty liver diseases, and atherosclerosis


The sulfated oxysterol 5-cholesten-3β, 25-diol 3-sulphate, a nuclear cholesterol metabolite that decreases lipid biosynthesis and increases cholesterol secretion and degradation, is provided as an agent to lower intracellular and serum cholesterol and/or triglycerides, and to prevent or treat lipid accumulation-associated inflammation and conditions associated with such inflammation. Methods which involve the use of this sulfated oxysterol to treat conditions associated with high cholesterol and/or high triglycerides and/or inflammation (e.g.
Virginia Commonwealth University


Conversion of a low viscosity ligno-cellulosic biomass slurry into polyols


A process for producing polyols from a low viscosity slurry comprising a thermally treated ligno-cellulosic biomass which has been subjected to a fiber shives reduction step is provided. Specifically, a continuous process for catalyzing the formation of polyol products, such as ethylene glycol and propylene glycol, from the low viscosity slurry is provided..
Biochemtex S.p.a.


Even carbon number paraffin composition and manufacturing same


Paraffin compositions including mainly even carbon number paraffins, and a method for manufacturing the same, is disclosed herein. In one embodiment, the method involves contacting naturally occurring fatty acid/glycerides with hydrogen in a slurry bubble column reactor containing bimetallic catalysts with equivalent particle diameters from about 10 to about 400 micron.
Reg Synthetic Fuels, Llc


Modeling material for forming photofabrication model in ink-jet three dimensional printing, supporting material for supporting the shape of photofabrication model on photofabrication and production photofabrication model


The present invention aims to provide a supporting material for supporting the shape of a photofabrication model on photofabrication in ink-jet three dimensional printing method in which the photocured product is excellent in solubility in water and is easy to remove after photofabrication, and the like. A modeling material for forming a photofabrication model in ink-jet three dimensional printing method containing a curable resin component with a weighted average of sp value of 9.0 to 10.3; and a supporting material for supporting the shape of a photofabrication model on photofabrication in ink-jet three dimensional printing method containing a water-soluble monofunctional ethylenically unsaturated monomer (f), polyoxypropylene glycol with a number average molecular weight of 100 to 5,000 and/or water (g), and a photopolymerization initiator (d)..
Keyence Corporation


Order a batch download of a huge number of patent PDFs. Bulk PDF Downloads This is a premium service.

Products comprising an extracellular matrix tissue material and osteogenic protein


Osteogenic compositions include a decellularized extracellular matrix tissue and bone morphogenic protein, preferably bmp-2. The compositions make beneficial use of the bmp, which can be used at relatively low doses and can bind to native components (e.g., native sulfated glycosaminoglycans such as heparin and/or heparan sulfate) remaining in the decellularized extracellular matrix tissue.
Muffin Incorporated


Absorbent article comprising a lotion composition for reducing adherence of feces or menses to the skin


An absorbent article, intended to be worn by a wearer, wherein at least a part of a body facing surface of that article has a lotion composition. The lotion composition includes at least one first compound which is liquid at 25° c.
The Procter & Gamble Company


Biopolymer drug loading method


A method of producing a drug-loaded poly (glycerol sebacate) (pgs) comprising providing pgs; dissolving at least one drug in a solvent; incubating the pgs in the solvent; and evaporating the solvent.. .
South Dakota Board Of Regents


Adjuvant composition, adjuvant preparation containing same, and kit


An adjuvant composition of the present invention contains lauryl alcohol and propylene glycol. Contents of the lauryl alcohol and the propylene glycol are 0.5 to 25% by mass and 8.0 to 99.5% by mass, relative to the total mass of the adjuvant composition, respectively.
Hisamitsu Pharmaceutical Co., Inc.


Modified binding proteins inhibiting the vegf-a receptor interaction


The present invention relates to binding proteins specific for vegf-a, in particular to recombinant binding proteins comprising a polyethylene glycol moiety and a binding domain, which inhibits vegf-axxx binding to vegfr-2. Examples of such recombinant binding proteins are proteins which comprise an ankyrin repeat domain with the desired binding specificity, and a polyethylene glycol moiety.
Molecular Partners Ag


Joint care composition


The present invention relates to a composition comprising curcuminoid with green tea polyphenol or with a combination of glycine, proline and hydroxyproline for use in preventing or treating osteoarthritis. It also relates to a method of preventing or treating osteoarthritis in mammals, the method comprising administering to said mammal a composition which comprises curcuminoid with green tea polyphenol or with a combination of glycine, proline and hydroxyproline..
Mars, Incorporated


Method of producing a substance with antimicrobial, antiviral, and immunostimulatory activities, a substance and a composition


A method of producing a substance with antimicrobial, antiviral, and immunostimulatory activities, particularly towards dendritic cells is proposed, provides for using the chopped potato sprouts as plant raw materials are extracted with water, then the aqueous extract is centrifuged, a salt agent is added, and the obtained saline solution is then concentrated using ultrafiltration through a 300-kd filter, then the solution is frozen for 24 hours, thawed, and filtered, and the pellet thus obtained is removed, and the raw peptidoglycan is precipitated from the solution by using an acidic salt agent and is further re-solubilized with alkali, then the alkaline solution is dialyzed against distilled water on a 12 kd filter, and the peptidoglycan having a molecular weight of 500 kd to 17000 kd is purified from the resulting solution using gel permeation chromatography.. .
Silezia Group Pte. Ltd


Natural sweetener


A repressive sweetener composition comprising at least two sugar alcohols, monk fruit, a rheology modifier, and tagatose wherein the repressive sweetener composition has a glycemic index that is less than a sum of the glycemic index of each component of the repressive sweetener composition. A sweetener composition prepared by: (i) dry blending in a fluidized bed a rheology modifier, tagatose, stevia extract, xanthan gum, a flavor blend, erythritol, and a second sugar alcohol to form a first mixture; (ii) spray depositing water onto the first mixture to generate a wet mixture; and (iii) removing excess moisture from the wet mixture to generate granules..
Natgood Ip, Llc


Application and pharmaceutical composition of preactivated and disaggregated shape-changed platelets


Preactivated and disaggregated shape-changed platelets, fixed shape-changed platelets, and a pharmaceutical composition thereof are used for treating acute and emergent inflammatory disease in a dosage of 1×106 to 1×108. Sc-plt is a disaggregated and activated platelet, the secretome from platelet activation has been deprived after sc-plt preparation but their membrane still preserve cell adhesion molecular and integrin glycoprotein (eg.

Inhibitors of diacylglycerol o-acyltransferase 1 (dgat-1) and uses thereof


The invention pertains to the use of fused bicyclo heterocyclic adducts of thiohydroxy pyridines or pyrimidines as diacylglycerol o-acyltransferase 1 (dgat-1) inhibitors to treat hyperlipidiemias and various diseases and disorders associated therewith. Other conditions also can be ameliorated or avoided, such as high postprandial triglycerides or diet-related hypertriglyceridemia, cardiovascular risk associated with excessive triglycerides, and insulin resistance/glucose intolerance in overweight patients, those with diabetes or other glucose metabolic disorders such as syndrome x and/or polycystic ovary disease..
Metabasis Therapeutics, Inc.


Treatment of erectile dysfunction and other indications


The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use of a hostile biophysical environment.
Strategic Science & Technologies, Llc


Treatment of erectile dysfunction and other indications


The present invention generally relates to the transdermal delivery of various compounds. In some aspects, transdermal delivery may be facilitated by the use of a hostile biophysical environment.
Strategic Science & Technologies, Llc


Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy


The present invention relates to methods for treating a disease associated with insulin resistance selected from a nonalcoholic fatty liver disease (nafld) and its sequelae, a lipodystrophic syndrome or a combination thereof with the selective pparγ agonist, int131 and optionally vitamin e or compositions thereof. Naflds that may be treated with methods and compositions of the present invention include, but are not limited to, simple nonalcoholic fatty liver and nonalcoholic steatohepatitis (nash).
Intekrin Therapeutics, Inc.


Monoacylglycerols for use in the treatment of malabsorption having a mechanical basis


Compositions comprising monoacylglycerols (mag), such as sn-1(3) mag, are administered to an individual having or at risk of malabsorption having a mechanical basis, such as malabsorption associated with a biliary fistula, a biliary obstruction, or short bowel syndrome from bowel surgery (resection) or bariatric surgery. Preferably the compositions are administered concurrently with fat-soluble nutrients.
Nestec S.a.


Monoacylglycerols and fat-soluble nutrients for use in the treatment of malabsorption having a non-mechanical basis


Compositions comprising monoacylglycerols (mag), such as sn-1(3) mag, and further comprising fat-soluble nutrients, such as fat-soluble vitamins and carotenoids, are administered to an individual having or at risk of malabsorption having a non-mechanical basis, such as malabsorption associated with chronic liver diseases, bacterial overgrowth in the small intestine, defective enterocyte functions, lymphatic disorders, celiac disease, crohn's disease, or zollinger-ellison syndrome. The compositions and the methods of using the compositions enhance absorption of fatty acids and the fat-soluble nutrients to address nutritional deficiencies due to malabsorption having a non-mechanical basis..
Nestec S.a.


Liquid dosage forms of sodium naproxen


Described herein are oral pharmaceutical compositions comprising liquid dosage forms of sodium naproxen in soft gel capsules. In one embodiment, the pharmaceutical composition comprises sodium naproxen, 0.2-1.0 mole equivalents of a de-ionizing agent per mole of naproxen, polyethylene glycol, and one or more solubilizers such as propylene glycol, polyvinyl pyrrolidone or a combination thereof..
Banner Life Sciences Llc


Antimicrobial compositions


Antimicrobial compositions and related methods are disclosed. The antimicrobial compositions include glycolic acid, an anionic surfactant, and at least one additional surfactant selected from anionic and nonionic surfactants..
Delaval Holding Ab


Tablet containing ferric citrate


The present invention provides a new preparation which is a tablet containing (1) ferric citrate, (2) a polyvinyl alcohol-polyethylene glycol graft copolymer, and (3) a polyvinyl alcohol-acrylic acid-methyl methacrylate copolymer. .
Japan Tobacco Inc.


Preparation of a powdery pharmaceutical composition by means of cryo-milling


A method for the preparation of a powdery pharmaceutical composition comprising a pharmaceutical excipient and a pharmaceutical component, wherein the pharmaceutical excipient is a polyalkylene glycol, the method comprising the step of grinding a mixture of the pharmaceutical excipient and the pharmaceutical component at a temperature below ambient temperature.. .
Grunenthal Gmbh




Gly topics:
  • Door Assembly
  • Swimming Goggles
  • Transverse
  • Alkoxylate
  • Fluoropolymer
  • Air Cleaning
  • Rotor Shaft
  • Aspect Ratio
  • Disconnect
  • Synchronization
  • Remote Control
  • Ethylene Glycol
  • Surfactant
  • Combustion
  • Steviol Glycosides


  • Follow us on Twitter
    twitter icon@FreshPatents

    ###

    This listing is a sample listing of patent applications related to Gly for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gly with additional patents listed. Browse our RSS directory or Search for other possible listings.


    1.1581

    5423

    2 - 1 - 112